Prognostic value of preoperative circulating tumor DNA in non-small cell lung cancer: a systematic review and meta-analysis.

Jiamin LuYuqian FengKaibo GuoLeitao Sun Shanming Ruan Kai Zhang

Published in: Journal of cancer research and clinical oncology (2024)

The evaluation of the prognostic value of preoperative ctDNA revealed that preoperative ctDNA might be used as a prognostic biomarker for patients with LUAD or those with stage I-II NSCLC. In addition, postoperative AT is recommended for NSCLC patients with positive preoperative ctDNA, regardless of the disease stage and subtype.

Keyphrases

circulating tumor
patients undergoing
cell free
circulating tumor cells
small cell lung cancer
single cell
single molecule
tyrosine kinase
epidermal growth factor receptor